Investor · Boston, MA
Christopher De Souza
Open Christopher in the network graph →Capital
$2.1M
across filings
Active
Nov 2021
to Dec 2023
Most-connected co-filers (130)
Jon Freeman · Maple Grove, MN11 sharedRichard Horan · Providence, RI8 sharedEllie A. Mcguire · Boston, MA7 sharedMatt V. Auriemma · MIAMI, FL5 sharedThomas J. Vasicek · Minneapolis, MN5 sharedScott Schorer · Boston, MA4 sharedElizabeth Peters · Portland, ME3 sharedMichael Brown Jr · New York, NY3 sharedJeffrey K. Rohrs · Indianapolis, IN3 sharedWilliam S. George · Boston, MA3 sharedJose A. Halperin · Boston, MA3 sharedDana Jones · Irving, TX3 sharedMatthew Angel · Cambridge, MA3 sharedSerrado Capital LLC · New York, NY3 sharedJoseph S. Atencio · Boston, MA3 sharedLubert-Adler Group Vii-B, LLC · Atlanta, GA3 sharedTheo Beack · San Diego, CA3 sharedLubert-Adler Group VII-B Holdings, LLC · Atlanta, GA3 sharedChristopher Rohde · Cambridge, MA3 sharedAdam Sachs · Cambridge, MA3 sharedMichael A. Chorev · Boston, MA3 sharedDana L. Schmaltz · Boston, MA3 sharedRaul R. Mcgregor · London, United Kingdom3 sharedMark R. Franklin · London, United Kingdom3 shared Recent filings (19)
Gila Therapeutics, Inc.Dec 2023 · 15 co-filers$10.0MGila Therapeutics, Inc.Dec 2023 · 15 co-filers$10.0MMellitus, LLCAug 2023 · 11 co-filers$750KMellitus, LLCAug 2023 · 11 co-filers$750KGila Therapeutics, Inc.Nov 2022 · 9 co-filers$5.0MGila Therapeutics, Inc.Nov 2022 · 9 co-filers$5.0MGila Therapeutics, Inc.Nov 2021 · 9 co-filers$1.3MGila Therapeutics, Inc.Nov 2021 · 9 co-filers$1.3MGila Therapeutics, Inc.Feb 2021 · 12 co-filers$500KGranatus Septem, LLCDec 2020 · 5 co-filers$750KServisFirst Bancshares, Inc.Oct 2020 · 27 co-filers$34.8MMellitus, LLCMay 2019 · 16 co-filers$2.8MGila Therapeutics, Inc.Mar 2019 · 10 co-filers$2.0MMellitus, LLCOct 2018 · 14 co-filers$1.7MNxt-ID, Inc.Nov 2017 · 26 co-filersServisFirst Bancshares, Inc.Nov 2017 · 25 co-filers$30.0MGranatus Septem, LLCOct 2017 · 5 co-filers$180KMETRICSTREAM INCOct 2017 · 37 co-filers$45.0MMETRICSTREAM INCOct 2017 · 39 co-filers$25.0MGranatus Septem, LLCAug 2017 · 3 co-filers$300KNxt-ID, Inc.Jul 2017 · 17 co-filersNxt-ID, Inc.Jul 2017 · 17 co-filersGila Therapeutics, Inc.Feb 2017 · 16 co-filers$500KGila Therapeutics, Inc.Feb 2017 · 16 co-filers$500K Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Christopher in the interactive graph →